NPK's Q2 earnings per share more than triple year over year while sales rise 21.7%, driven by higher Defense shipments and a tariff refund that boosts Housewares profitability.
SPB's strong Q3 results benefit from broad-based sales growth and margin expansion, leading to a higher 2026 EBITDA outlook.
GE's commercial engines unit surges on services, spare parts and LEAP deliveries, while major orders support its 2026 growth outlook.
JNJ's Innovative Medicine unit posts strong Q2 growth despite Stelara's patent loss. See what's fueling momentum into H2 2026.
MRSH beats Q2 earnings estimates as Consulting and Risk & Insurance Services fuel revenue growth despite higher operating expenses.
Seventeen companies in the United States have reported or been affected by cyber incidents this year amid a worldwide surge in artificial intelligence-driven cyberattacks, Reuters reported Friday (July 17). The latest company to report a cyberattack is Fairlife, a dairy company owned by The Coca-Cola Co.
Wells Fargo's Wealth & Investment Management business has invested over $1 billion over the past several years to modernize its technology platform, with a new generative artificial intelligence-powered suite of tools for financial advisors being the latest addition, Wells Fargo Chairman and CEO Charlie Scharf said Tuesday (July 14) during an earnings call.
AXON's Connected Devices business is accelerating with strong demand for TASERs, body cameras and platform solutions, lifting its 2026 outlook.
Digital bank Nubank's Mexican operation, Nu Mexico, has received authorization to begin operations as a bank and now has 30 calendar days to complete its transformation into a bank, the company said in a Friday (July 10) press release.
GE's defense business is gaining from strong orders, major contracts and rising military demand, supporting growth expectations for 2026.
Seven & i Holdings raised its annual guidance after the war-driven surge in gasoline prices boosted earnings at its North American convenience-store business, sending quarterly net profit higher.
Danaher's Biotechnology segment posts 7% core revenue growth as bioprocessing demand strengthened, even as weaker product demand created headwinds.